UNSETTLING DRUG PATENT SETTLEMENTS: A FRAMEWORK FOR PRESUMPTIVE ILLEGALITY.
- Published in:
- Michigan Law Review, 2009, v. 108, n. 1, p. 37
- By:
- Publication type:
- Article
Works matching DE "DRUG patent lawsuits"
Results: 24
1
2
Drug Patent Settlements Around the World.
- Published in:
- Antitrust Bulletin, 2017, v. 62, n. 4, p. 770, doi. 10.1177/0003603X17733357
- By:
- Publication type:
- Article
3
AIA PROCEEDINGS: A PRESCRIPTION FOR ACCELERATING THE AVAILABILITY OF GENERIC DRUGS.
- Published in:
- Emory Law Journal, 2017, v. 66, n. 4, p. 1007
- By:
- Publication type:
- Article
4
SPARSE PATENT PROTECTION FOR RESEARCH TOOLS: EXPANSION OF THE SAFE HARBOR HAS CHANGED THE RULES.
- Published in:
- Emory Law Journal, 2014, v. 63, n. 3, p. 749
- By:
- Publication type:
- Article
5
Patents Court maintains injunction protecting Warner-Lambert's second medical use patent for pregabalin.
- Published in:
- Journal of Intellectual Property Law & Practice, 2017, v. 12, n. 5, p. 360, doi. 10.1093/jiplp/jpx051
- By:
- Publication type:
- Article
6
Patents Court finds medac's methotrexate formulation patent invalid.
- Published in:
- Journal of Intellectual Property Law & Practice, 2016, v. 11, n. 5, p. 320, doi. 10.1093/jiplp/jpw040
- By:
- Publication type:
- Article
7
Insufficiency finally upheld as ground for invalidity of antibody claim.
- Published in:
- Journal of Intellectual Property Law & Practice, 2013, v. 8, n. 11, p. 809, doi. 10.1093/jiplp/jpt173
- By:
- Publication type:
- Article
8
REANALYZING REVERSE-PAYMENT SETTLEMENTS: A SOLUTION TO THE PATENTEE'S DILEMMA.
- Published in:
- Cornell Law Review, 2014, v. 99, n. 5, p. 1227
- By:
- Publication type:
- Article
9
Update on Antitrust and Pay-for-Delay: Evaluating "No Authorized Generic" and "Exclusive License" Provisions in Hatch-Waxman Settlements.
- Published in:
- San Diego Law Review, 2018, v. 55, n. 1, p. 159
- By:
- Publication type:
- Article
10
Looking for Venue in the Patently Right Places: A Parallel Study of the VENUE Act and Venue in ANDA Litigation.
- Published in:
- San Diego Law Review, 2018, v. 55, n. 1, p. 183
- By:
- Publication type:
- Article
11
A Hard Pill to Swallow: A Critical Look at Eli Lilly & Co.'s NAFTA Challenge of the Canadian Patent Regime, and Its Potential Side Effects.
- Published in:
- International Lawyer, 2013, v. 47, n. 3, p. 519
- By:
- Publication type:
- Article
12
Pharmaceutical; Trademark; Patents; News.
- Published in:
- Journal of Generic Medicines, 2014, v. 11, n. 3/4, p. 150, doi. 10.1177/1741134315579526
- By:
- Publication type:
- Article
13
What is the intention with skinny labels and second medical use patents?
- Published in:
- Journal of Generic Medicines, 2014, v. 11, n. 3/4, p. 166, doi. 10.1177/1741134315587063
- By:
- Publication type:
- Article
14
Esomeprazole in the Australian courts: The acid test.
- Published in:
- Journal of Generic Medicines, 2013, v. 10, n. 2, p. 115, doi. 10.1177/1741134313502979
- By:
- Publication type:
- Article
15
Pharmaceutical; Trademark; Patents; News.
- Published in:
- Journal of Generic Medicines, 2013, v. 10, n. 2, p. 134, doi. 10.1177/1741134313498401
- By:
- Publication type:
- Article
16
Court sides with generics company over Tamiflu patent.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 6, p. 408, doi. 10.1038/nrd4352
- Publication type:
- Article
17
Patently unclear.
- Published in:
- Chemistry & Industry, 2013, v. 77, n. 9, p. 45, doi. 10.1002/cind.7709_13.x
- Publication type:
- Article
18
The Intersection of Patent Infringement and Antitrust Liability in Abbreviated New Drug Application Litigation.
- Published in:
- Journal of Dispute Resolution, 2014, v. 2014, n. 1, p. 51
- By:
- Publication type:
- Article
19
Resolving Reverse-Payment Settlements with the Smoking Gun of Stock Price Movements.
- Published in:
- 2016
- By:
- Publication type:
- Essay
20
UNCERTAINTY AND REVERSE PAYMENTS.
- Published in:
- Tennessee Law Review, 2016, v. 84, n. 1, p. 99
- By:
- Publication type:
- Article
21
The Simple Math of Royalties and Drug Competition During the 180-Day Generic Exclusivity Period.
- Published in:
- Journal of Competition Law & Economics, 2024, v. 20, n. 1/2, p. 50, doi. 10.1093/joclec/nhae001
- By:
- Publication type:
- Article
22
Generic Entry Before the Agreed-Upon Date in Pharmaceutical Patent Settlements.
- Published in:
- Journal of Competition Law & Economics, 2020, v. 16, n. 2, p. 188, doi. 10.1093/joclec/nhaa007
- By:
- Publication type:
- Article
23
HATCH-WAXMAN PATENT LITIGATION AND INTER PARTES REVIEW: A NEW SORT OF COMPETITION.
- Published in:
- Alabama Law Review, 2017, v. 69, n. 1, p. 59
- By:
- Publication type:
- Article
24
BIOTECHNOLOGY PATENT LAW TOP TEN OF 2018 BROAD WINS, SOVEREIGNTY LOSES, AND PATENT DANCE.
- Published in:
- Akron Law Review, 2019, v. 52, n. 3, p. 637
- By:
- Publication type:
- Article